Stacey Rudd

ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with 89Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocol.

Fiona Hegi-Johnson, Stacey E Rudd, Christian Wichmann, Tim Akhurst, Peter Roselt, Jenny Trinh, Thomas John, Lisa Devereux, Paul S Donnelly, Rod Hicks, Andrew M Scott, Daniel Steinfort, Stephen Fox, Benjamin Blyth, Sagun Parakh, Gerard G Hanna, Jason Callahan, Kate Burbury, Michael MacManus

Journal article  |  2022  |  BMJ Open

BACKGROUND: ImmunoPET is a multicentre, single arm, phase 0-1 study that aims to establish if 89Zr-durvalumab PET/CT can be used t..

P1.10-02 ImmunoPET: A Phase 0/1 Study Characterising PD-L1 with 89Zr-Durvalumab (MEDI4736) PET/CT in Stage III NSCLC Patients Receiving Chemoradiation

M MacManus, S Rudd, P Roselt, C Wichmann, J Callahan, T John, A Scott, P Donnelly, G Hanna, F Hegi-Johnson

Journal article  |  2022  |  Journal of Thoracic Oncology

MA09.05 Increased PD-L1 Tracer Uptake in Recently-irradiated Lesions in NSCLC: Preliminary Results of a Phase 0 Trial (ImmunoPET) of a Novel PET Tracer

F Hegi-Johnson, T Akhurst, S Rudd, P Donnelly, A Scott, J Callahan, P Roselt, T John, S Sithara, C Wichmann, G Hanna, M MacManus

Journal article  |  2022  |  Journal of Thoracic Oncology

P2.03-01 Initial Biodistribution Data of ImmunoPET A Phase 0/1 Study Characterising PD-L1 with 89 Zr-Durvalumab (MEDI4736) PET/CT

F Hegi-Johnson, S Rudd, J Callahan, C Wichmann, T Akhurst, P Roselt, T John, P Donnelly, A Scott, G Hanna, M MacManus

Journal article  |  2022  |  Journal of Thoracic Oncology

Imaging immunity in patients with cancer using positron emission tomography

Fiona Hegi-Johnson, Stacey Rudd, Rodney J Hicks, Dirk De Ruysscher, Joseph A Trapani, Thomas John, Paul Donnelly, Benjamin Blyth, Gerard Hanna, Sarah Everitt, Peter Roselt, Michael P MacManus

Journal article  |  2022  |  NPJ PRECISION ONCOLOGY

Immune checkpoint inhibitors and related molecules can achieve tumour regression, and even prolonged survival, for a subset of can..

Fully Automated Radiosynthesis of [Zr-89]Zr-DFOSq-Durvalumab for Clinical PET Imaging of PD-L1

C Wichmann, S Poniger, N Guo, P Roselt, S Rudd, PS Donnelly, F Hegi-Johnson, M MacManus, AM Scott

Conference Proceedings  |  2021  |  EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB (R) Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models (Jul, 10.1007/s11307-021-01620-1, 2021)

Vasilios Liapis, William Tieu, Nicole L Wittwer, Tessa Gargett, Andreas Evdokiou, Prab Takhar, Stacey E Rudd, Paul S Donnelly, Michael P Brown, Alexander H Staudacher

Journal article  |  2021  |  MOLECULAR IMAGING AND BIOLOGY

This article was updated to amend the Acknowledgments.

Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB (R) Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models

Vasilios Liapis, William Tieu, Nicole L Wittwer, Tessa Gargett, Andreas Evdokiou, Prab Takhar, Stacey E Rudd, Paul S Donnelly, Michael P Brown, Alexander H Staudacher

Journal article  |  2021  |  MOLECULAR IMAGING AND BIOLOGY

PURPOSE: Early detection of tumor treatment responses represents an unmet clinical need with no approved noninvasive methods. DAB4..

Enzyme mediated incorporation of zirconium-89 or copper-64 into a fragment antibody for same day imaging of epidermal growth factor receptor

Stacey E Rudd, Jessica K Van Zuylekom, Anna Raicevic, Lesley A Pearce, Carleen Cullinane, Charlotte C Williams, Timothy E Adams, Rodney J Hicks, Paul S Donnelly

Journal article  |  2021  |  CHEMICAL SCIENCE

Identification of tumors which over-express Epidermal Growth Factor Receptor (EGFR) is important in selecting patients for anti-EG..

Automated radiosynthesis of [Zr-89]ZrDFOSq-Durvalumab on the iPHASE MultiSyn module

Christian Wichmann, Stan Poniger, Nancy Guo, Peter Roselt, Stacey Rudd, Paul Donnelly, Fiona Hegi-Johnson, Michael MacManus, Andrew Scott

Conference Proceedings  |  2021  |  JOURNAL OF NUCLEAR MEDICINE